Two FDA drug review Directors to leave the agency, with no permanent replacements in place

April 27, 2018
Medical Communications, Sales and Marketing FDA, pharma

The FDA has revealed that two of its prominent Directors are set to retire from the agency, leaving three of …

alexion_sign

Investigational Alexion drug proves non-inferior to Soliris in rare blood disease

April 27, 2018
Medical Communications, Research and Development Alexion, paroxysmal nocturnal haemoglobinuria, pharma, soliris

Alexion has lifted the curtain on new data for its C5 complement inhibitor ALXN1210, demonstrating its non-inferiority to another of …

fda2outsideweb

FDA moots a return look at Acadia’s lead drug

April 27, 2018
Medical Communications, Sales and Marketing Acacia, FDA, nuplazid, pharma

Following a non-profit report that higher rates of death were associated with Acadia Pharmaceuticals’ Nuplazid, Scott Gottlieb has made comments …

becca

Health to hand

April 26, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Breast Cancer Care, biotech, drugs, pharma, pharmaceutical

Kristina Barrick is the Digital Innovation Manager at Breast Cancer Care and leads on the development of BECCA, the Breast …

shutterstock_92671375

US court upholds verdict voiding MSD’s claim to $200m from Gilead in patent dispute

April 26, 2018
Sales and Marketing Gilead, MSD, Merck, harvoni, hepatitis C, pharma, sovaldi

MSD has taken a legal hit after a US appeals court upheld a ruling that the pharma giant had illicitly …

houses-of-parliament-1055056_960_720

House of Lords unloads both barrels on Government’s life science strategy approach

April 26, 2018
Medical Communications ABPI, Life Sciences Industrial Strategy, UK government, biotech, drugs, pharma, pharmaceutical

The Life Sciences Industrial Strategy was supposed to forge a path forward for the industry, despite pressures from Brexit, to …

newspapers_jon_s

UK media coverage vastly underrepresents older cancer patients and their risk, study finds

April 26, 2018
Medical Communications, Research and Development Cancer, Cancer Research UK, UK, University of Glasgow, pharma

A Cancer Research UK-funded study undertaken by the University of Glasgow has revealed that representation and coverage of cancer patients …

Takeda announce new UK MD, ahead of possible Shire transformation

April 26, 2018
Medical Communications Shire, Takeda, biotech, drugs, pharma, pharmaceutical

“Jon’s appointment comes at an exciting time for the company” reads the company press on annoucing its new Managing Director …

hands-981400_960_720

Common antidepressants linked to dementia risk

April 26, 2018
Medical Communications anticholinergic, biotech, dementia, drugs, pharma, pharmaceutical

A large study looking at the public’s use of anticholinergic drugs, such as those used to treat depression and Parkinson’s, …

shutterstock_212432119

Lilly’s arthritis drug found to prevent potentially lethal stem cell transplant complications

April 25, 2018
Research and Development Cancer, Eli Lilly, JAK inhibitors, Stem cells, baricitinib, graft-versus-host disease, pharma

Researchers at St Louis Washington University School of Medicine have uncovered a promising extra application of a particular Janus Kinase …

hans-bishop_2x

Juno CEO and Co-founder steps down in wake of Celgene acquisition

April 25, 2018
Medical Communications, Research and Development Celgene, appointment, juno therapeutics, pharma

Hans Bishop, CEO and Co-founder of Juno Therapeutics who helped set up the company in 2013 and has since grown …

phone_health

Novartis forges forward into digital pharma with FocalView app

April 25, 2018
Medical Communications, Research and Development FocalView, Novartis, biotech, drugs, pharma, pharmaceutical

There is a growing trend in big pharma to talk up the potential for digital technology to revolutionise operations and …

john_reed

Sanofi makes ex-Roche scientist new R&D chief

April 25, 2018
Medical Communications, Research and Development Roche, Sanofi, biotech, drugs, pharma, pharmaceutical

With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes …

china_block_001_takeda

$64bn Takeda-Shire mega merger inches closer to closing

April 25, 2018
Research and Development, Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical

From March onwards, Takeda has been nudging a deal with Shire onwards through repeatedly improved offers, which has seen the …

MHRA bans sodium valproate in the UK following birth defect controversy

April 24, 2018
Manufacturing and Production, Research and Development, Sales and Marketing MHRA, Sanofi, Sodium valproate, bipolar, epilepsy, pharma

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced that sodium valproate, a drug used in the treatment …

Lilly’s arthritis drug hits trouble at FDA committee

April 24, 2018
Manufacturing and Production, Sales and Marketing Eli Lilly, Incyte, biotech, drugs, pharma, pharmaceutical, rheumatoid arthritis

FDA’s advisory committee were openly conflicted about deciding on the safety of Eli Lilly and Incyte’s drug, baricitinib, for the …

astrazeneca_logo_building

AZ’s combo woes continue, with failure in lung cancer

April 24, 2018
Manufacturing and Production, Research and Development AstraZeneca, Imfinzi, biotech, drugs, pharma, pharmaceutical

AstraZeneca has been hit by a fresh blow in its search for an immunotherapy combination treatment that could differentiate it …

prothena-37882-2

Prothena collapses on double trial failure

April 23, 2018
Manufacturing and Production, Research and Development Prothena Therapeutics, biotech, drugs, pharma, pharmaceutical

Shares in Prothena have dropped by close to 70% on the news that two of its trials into its lead …

tony_green_edit

Living with atrial fibrillation

April 23, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing KardiaMobile, Tony Green, atrial fibrillation, patient experience

Tony Green discusses the difficulty in pinning down his diagnosis of the irregular heart rhythm condition, until his use of …

The Gateway to Local Adoption Series

Latest content